Denali Therapeutics Inc. (DNLI) insider trading.
In Q3 2026, insiders at Denali Therapeutics Inc. reported 6 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $435K.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 5
- Net shares, P minus S
- -18,718
- Insiders
- 4
- Last filed
- 2026-09-09
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Thornberry Nancy | Director | 2 | 0 | 2 |
| Schuth Alexander O. | Officer · COFO and Secretary | 2 | 0 | 2 |
| Chin Peter Scott | Officer · Chief Medical Officer | 1 | 0 | 1 |
| Watts Ryan J. | Director, Officer · President and CEO | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-04 | Chin Peter Scott | S (D) | 1,654 | $22.29 | 204,538 | Form 4 |
| 2026-09-02 | Thornberry Nancy | S (D) | 10,824 | $22.85 | 20,301 | Form 4 |
| 2026-09-02 | Thornberry Nancy | S (D) | 615 | $23.74 | 19,686 | Form 4 |
| 2026-09-01 | Schuth Alexander O. | S (D) | 2,768 | $23.44 | 278,995 | Form 4 |
| 2026-08-12 | Watts Ryan J. | G (D) | 32,220 | $0 | 2,120,384 | Form 4 |
| 2026-08-11 | Schuth Alexander O. | S (D) | 2,857 | $25.07 | 281,763 | Form 4 |
Transaction codes in this quarter
Get DNLI insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1714899&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · DNLI company page · Denali Therapeutics Inc. on SEC.gov
Questions
Are insiders buying or selling Denali Therapeutics Inc. (DNLI)?
In Q3 2026, insiders at Denali Therapeutics Inc. reported 6 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $435K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Denali Therapeutics Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/dnli.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.